FDA
-
-
-
-
-
-
-
TG Therapeutics presents BRIUMVI data at multiple sclerosis forum
-
-
-
-
-
-
-
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
-
-
-
-
-
-
-
TG Therapeutics reports six-year BRIUMVI data at ECTRIMS conference
-
-
-
-
-
-
-
TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program
-
-
-
-
-
-
-
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
-
-
-
-
-
-
-
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
-
-
-
-
-
-
-
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

